Filter
1029
Text search:
therapeutic
agents
Featured
Recommendations
131
New Publications
265
Language
Document type
No document type
514
Guidelines
225
Studies & Reports
173
Manuals
58
Strategic & Response Plan
20
Training Material
14
Fact sheets
11
Situation Updates
8
Brochures
2
Resource Platforms
2
Infographics
1
Online Courses
1
Countries / Regions
India
76
South Africa
41
Kenya
34
Global
34
Ethiopia
27
Uganda
22
Nigeria
20
Zambia
17
Tanzania
16
Latin America and the Carribbean
16
Bangladesh
14
Sierra Leone
13
Liberia
13
Nepal
13
Ghana
12
Rwanda
12
Western and Central Europe
11
Myanmar / Burma
10
Philippines
8
Congo, Democratic Republic of
7
Namibia
7
Africa
7
Cambodia
6
Lesotho
6
Russia
6
Burkina Faso
5
USA
5
Zimbabwe
5
Guinea
4
Thailand
4
Indonesia
4
Malawi
4
Mozambique
4
Brazil
4
Ukraine
4
Senegal
3
Mali
3
Cameroon
3
Haiti
3
Germany
3
Syria
3
Eswatini/ Swaziland
3
North Macedonia
3
Spain
3
South Sudan
2
Iraq
2
Afghanistan
2
Sudan
2
Benin
2
Botswana
2
Yemen
2
Middle East and North Africa
2
South–East Asia Region
2
Asia
2
Fiji
2
Bhutan
2
Venezuela
2
Tajikistan
2
Georgia
2
Vietnam
2
Gabon
2
Somalia
1
Pakistan
1
Jordan
1
Turkey
1
China
1
Malaysia
1
Singapore
1
Peru
1
Serbia
1
Colombia
1
Libya
1
Angola
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Solomon Islands
1
Eastern Europe
1
Albania
1
Armenia
1
Laos
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Denmark
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
393
Clinical Guidelines
149
Public Health
47
Women & Child Health
42
Key Resources
34
Pharmacy & Technologies
17
Capacity Building
12
Toolboxes
AMR
150
Mental Health
75
Pharmacy
69
HIV
65
TB
52
COVID-19
43
NTDs
41
Ebola & Marburg
34
NCDs
33
Caregiver
30
Rapid Response
17
Malaria
13
Disability
10
Refugee
10
Planetary Health
9
Conflict
8
Natural Hazards
6
Specific Hazards
5
2.0 Rapid Response
5
Cholera
3
Global Health Education
3
Social Ethics
3
Polio
2
Zika
2
Health Financing Toolbox
1
Latest update: 29 De 2021. Slideset updated regularly to include the latest data and guidance on non-therapeutic and therapeutic treatments for COVID-19, including authorized and investigational
...
In aquaculture, antibiotics have been used mainly for therapeutic purposes and as prophylactic agents. The contribution to antimicrobial resistance of antibiotics used in aquaculture is reviewed her
...
This comprehensive intermediate level course is for clinicians caring for patients with suspected or confirmed Ebola virus disease (EVD). Modules provide information on screening and triage, infection prevention and control, laboratory diagnostics, organization of the Ebola Treatment Centre (ETC), c
...
Leishmaniasis is a vector-borne tropical/subtropical disease caused by an intracellular parasite transmitted to humans by sand fly bite. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide reports include 1.5–2 million new cases each year, more than 300 million at
...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f
...
Antimalarial chemotherapy is crucial for reducing morbidity, mortality, and drug resistance, and is the cornerstone of malaria control. Existing antimalarial drugs act at different stages of the parasite’s life cycle. These drugs range from classic agent
...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being
...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an
...
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi
...
at the World Trade Organization (WTO) Trade Related Aspects of Intellectual Property Rights (TRIPs) Council
23 Febur. 2021
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,
...
Published: April 26, 2017 https://doi.org/10.1371/journal.pone.0176004
Antimicrobial agents play an indispensable role in animal health and welfare management. At the same time, the need for prudent use is obvious to ensure good food safety outcomes and to manage the potential risk of antimicrobial resistance. The emer
...
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. Th
...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial
...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr
...
Évaluation du programme burkinabé dans les districts de Kaya et de Zorgho
Objectif. L’objectif central de cette thèse est d’évaluer, dans des conditions réelles d’implantation, les effets du programme burkinabé de prise en charge communautaire du paludisme sur le recours aux soins de
...
